Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion type Assertion NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_head.
- NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion description "[These pre-B and null lymphocytes contain p19 and p24 antigens (80% of cells), have the HTLV-I genome, and are able to transform normal T lymphocytes in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_provenance.
- NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion evidence source_evidence_literature NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_provenance.
- NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion SIO_000772 6331549 NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_provenance.
- NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion wasDerivedFrom befree-2016 NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_provenance.
- NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_assertion wasGeneratedBy ECO_0000203 NP1305732.RA2VXL3qqrVGIRBsdZo-biC4vw7QAcv5ae31iOQETId6A130_provenance.